Bio-Connect

ELISA Kit for Osteoglycin (OGN)

SEC688HU
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Osteoglycin (OGN)
  • Delivery Days Customer
    12
  • Assay Detection Range
    31.2-2,000pg/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Osteoglycin (OGN) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high ...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 12.2pg/mL
  • Assay Test Principle
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Osteoglycin (OGN). Standards or samples are then added to the appropriate microtiter ...
  • Assay Time
    3h
  • Certification
    Research Use Only
  • UNSPSC
    41116158

References

  • Woessner MN, Hiam D, Smith C, et al. Osteoglycin Across the Adult Lifespan. J Clin Endocrinol Metab. 2022,107(4):e1426-e1433. doi: 10.1210/clinem/dgab861
    Read this paper
  • Yang Y, Wu QH, Li Y, et al. Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. J Hum Hypertens. 2018,32(8-9):564-571. doi: 10.1038/s41371-018-0077-7
    Read this paper
  • Hu X, Li YQ, Li QG, et al. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway. J Exp Clin Cancer Res. 2018,37(1):41. doi: 10.1186/s13046-018-0718-2
    Read this paper
  • Baek SH, Cha RH, Kang SW, et al. Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. Tohoku J Exp Med. 2017,242(4):281-290. doi: 10.1620/tjem.242.281
    Read this paper
  • Tanaka KI, Kanazawa I, Kaji H, et al. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Bone. 2017,95:5-10. doi: 10.1016/j.bone.2016.11.007
    Read this paper